{"id":"NCT01129102","sponsor":"Nobelpharma","briefTitle":"Efficacy and Safety Study of NPC-01 to Treat Dysmenorrhea","officialTitle":"Phase 3, Placebo Controlled, Randomized, Double-blinded, Nonsteroidal Antiinflammatory Drug add-on, Clinical Trial of NPC-01 for Treatment of Dysmenorrhea","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2010-05","primaryCompletion":"2011-04","completion":"2011-04","firstPosted":"2010-05-24","resultsPosted":"2014-06-17","lastUpdate":"2025-03-05"},"enrollment":215,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"TRIPLE","primaryPurpose":"TREATMENT"},"conditions":["Dysmenorrhea"],"interventions":[{"type":"DRUG","name":"NPC-01","otherNames":[]},{"type":"DRUG","name":"IKH-01","otherNames":[]},{"type":"DRUG","name":"Placebo","otherNames":[]}],"arms":[{"label":"NPC-01","type":"EXPERIMENTAL"},{"label":"IKH-01","type":"ACTIVE_COMPARATOR"},{"label":"Placebo","type":"PLACEBO_COMPARATOR"}],"summary":"The purpose of this study is to determine whether NPC-01 is effective in the treatment of dysmenorrhea.","primaryOutcome":{"measure":"Patient Response to Treatment for Dysmenorrhea, as Evaluated by Difference of Total Dysmenorrhea Score (Baseline/Pretreatment-End of Treatment)","timeFrame":"16weeks","effectByArm":[{"arm":"NPC-01","deltaMin":4.1,"sd":1},{"arm":"Placebo","deltaMin":4.2,"sd":0.95}],"pValues":[]},"eligibility":{"minAge":"16 Years","sex":"FEMALE","healthyVolunteers":false,"inclusionCount":1,"exclusionCount":2},"locations":{"siteCount":0,"countries":[]},"refs":{"pmids":["37523477","27717552"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":0,"n":107},"commonTop":["Metrorrhagia","Nasopharyngitis","Oligomenorrhoea","Headache","Nausea"]}}